Zevra’s Arimoclomol Brings Efficacy Questions To First Genetic Metabolic Diseases Adcomm

Wrapped package
The FDA's external advisors will consider a package of confirmatory trial evidence for arimoclomol. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

More from US FDA Performance Tracker

More from Regulatory Trackers